Second-generation proteasome inhibitor carfilzomib enhances doxorubicin-induced cytotoxicity and apoptosis in breast cancer cells

Yonghua Shi(South China University of Technology), Hong Zhang(Huaibei Normal University)
Oncotarget
September 15, 2016
Cited by 31


Related Papers